{"id":52963,"date":"2024-11-27T13:56:40","date_gmt":"2024-11-27T11:56:40","guid":{"rendered":"https:\/\/www.fyb.de\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/"},"modified":"2024-11-27T13:56:40","modified_gmt":"2024-11-27T11:56:40","slug":"highlight-capital-china-acquires-stake-in-biotech-company-itm","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/","title":{"rendered":"HighLight Capital China acquires stake in biotech company ITM"},"content":{"rendered":"

G\u00fctersloh\/Paderborn\/Bielefeld\/Detmold \u2014 High\u00adLight Capi\u00adtal (HLC), a private equity fund from China specia\u00adli\u00adzing in the health\u00adcare and biotech sectors, has acqui\u00adred a stake in the biotech company ITM Isotope Tech\u00adno\u00adlo\u00adgies Munich SE (ITM). ITM is a leading radio\u00adphar\u00admaceu\u00adti\u00adcal biotech company head\u00adquar\u00adte\u00adred in Munich. BRANDI Rechts\u00adan\u00adw\u00e4lte advi\u00adsed High\u00adLight Capi\u00adtal on the invest\u00adment in biotech company ITM. With its stra\u00adte\u00adgic invest\u00adment, High\u00adLight Capi\u00adtal under\u00adlines its commit\u00adment to finding invest\u00adments in high-growth compa\u00adnies in the radio\u00adphar\u00admaceu\u00adti\u00adcal sector. High\u00adLight Capi\u00adtal<\/strong> is a private invest\u00adment firm dedi\u00adca\u00adted to crea\u00adting long-term value by foste\u00adring tech\u00adno\u00adlo\u00adgi\u00adcal inno\u00adva\u00adtion. In selec\u00adting suita\u00adble compa\u00adnies, HLC draws on in-depth know\u00adledge of chemis\u00adtry, biology and mate\u00adri\u00adals science, utili\u00adzing its own indus\u00adtry rese\u00adarch and compre\u00adhen\u00adsive services. HLC curr\u00adently mana\u00adges over 3.8 billion US dollars and is repre\u00adsen\u00adted in major finan\u00adcial centers such as Tokyo, Shang\u00adhai, Hong Kong and Boston. High\u00adLight Capi\u00adtal recei\u00adved compre\u00adhen\u00adsive legal advice on the inter\u00adna\u00adtio\u00adnal private equity tran\u00adsac\u00adtion from a cross-loca\u00adtion M&A team of the law firm BRANDI Rechts\u00adan\u00adw\u00e4lte led by G\u00fcters\u00adloh part\u00adner Dr. Cars\u00adten Chris\u00adto\u00adphery<\/strong>. Advi\u00adsor High\u00adLight Capi\u00adtal, Shang\u00adhai, China: BRANDI Rechts\u00adan\u00adw\u00e4lte G\u00fctersloh\/Paderborn\/Bielefeld\/Detmold
\n<\/strong>
\n Dr. Cars\u00adten Chris\u00adto\u00adphery, Part\u00adner (Lead, Corporate\/M&A), G\u00fctersloh
\nDr. Franz Tepper, Part\u00adner (Corporate\/M&A), G\u00fctersloh
\nDr. S\u00f6rren Kiene, Part\u00adner (Commer\u00adcial), G\u00fctersloh
\nDr. Chris\u00adtoph Worms, Part\u00adner (Public Law), Paderborn
\nDr. R\u00fcdi\u00adger Osten, Part\u00adner (Commer\u00adcial), Detmold
\nJannis Riedl, Asso\u00adciate (Corporate\/M&A), G\u00fctersloh
\nDr. Clemens Meyer, Asso\u00adciate (Corporate\/M&A), G\u00fctersloh
\nFeli\u00adcia Deppe-Hietel, Asso\u00adciate (Public Law), Pader\u00adborn Advi\u00adsor ITM Isotope Tech\u00adno\u00adlo\u00adgies Munich SE: JFB Rechts\u00adan\u00adwalts\u00adge\u00adsell\u00adschaft mbH, M\u00fcnsing<\/strong>
\nDr. Justus Fritz Binder, Part\u00adner (Lead, Corporate\/M&A)
\nFrank Mizera, Asso\u00adciate (Corporate\/M&A)<\/p>\n","protected":false},"excerpt":{"rendered":"

G\u00fctersloh\/Paderborn\/Bielefeld\/Detmold \u2014 High\u00adLight Capi\u00adtal (HLC), a private equity fund from China specia\u00adli\u00adzing in the health\u00adcare and biotech sectors, has acqui\u00adred a stake in the biotech company ITM Isotope Tech\u00adno\u00adlo\u00adgies Munich SE (ITM). ITM is a leading radio\u00adphar\u00admaceu\u00adti\u00adcal biotech company head\u00adquar\u00adte\u00adred in Munich. BRANDI Rechts\u00adan\u00adw\u00e4lte advi\u00adsed High\u00adLight Capi\u00adtal on the invest\u00adment in biotech company ITM. With [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":52961,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1367,1368,1369,1372],"tags":[],"class_list":["post-52963","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-investors","category-consultant"],"yoast_head":"\nHighLight Capital China acquires stake in biotech company ITM - FYB Financial Yearbook<\/title>\n<meta name=\"description\" content=\"G\u00fctersloh\/Paderborn\/Bielefeld\/Detmold - HighLight Capital (HLC), a private equity fund from China specializing in the healthcare and biotech sectors, has acquired a stake in the biotech company ITM Isotope Technologies Munich SE (ITM). ITM is a leading radiopharmaceutical biotech company headquartered in Munich. BRANDI Rechtsanw\u00e4lte advised HighLight Capital on the investment in ITM.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HighLight Capital China acquires stake in biotech company ITM - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"G\u00fctersloh\/Paderborn\/Bielefeld\/Detmold - HighLight Capital (HLC), a private equity fund from China specializing in the healthcare and biotech sectors, has acquired a stake in the biotech company ITM Isotope Technologies Munich SE (ITM). ITM is a leading radiopharmaceutical biotech company headquartered in Munich. BRANDI Rechtsanw\u00e4lte advised HighLight Capital on the investment in ITM.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-27T11:56:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/dr-carsten-christophery-brandi-ra-brandi.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"686\" \/>\n\t<meta property=\"og:image:height\" content=\"435\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"HighLight Capital China acquires stake in biotech company ITM\",\"datePublished\":\"2024-11-27T11:56:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/\"},\"wordCount\":291,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/dr-carsten-christophery-brandi-ra-brandi.jpg\",\"articleSection\":[\"General\",\"Featured\",\"Private equity\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Lawyers, tax consultants, auditors\",\"Investors\",\"Consultant\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/\",\"url\":\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/\",\"name\":\"HighLight Capital China acquires stake in biotech company ITM - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/dr-carsten-christophery-brandi-ra-brandi.jpg\",\"datePublished\":\"2024-11-27T11:56:40+00:00\",\"description\":\"G\u00fctersloh\/Paderborn\/Bielefeld\/Detmold - HighLight Capital (HLC), a private equity fund from China specializing in the healthcare and biotech sectors, has acquired a stake in the biotech company ITM Isotope Technologies Munich SE (ITM). ITM is a leading radiopharmaceutical biotech company headquartered in Munich. BRANDI Rechtsanw\u00e4lte advised HighLight Capital on the investment in ITM.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/dr-carsten-christophery-brandi-ra-brandi.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/dr-carsten-christophery-brandi-ra-brandi.jpg\",\"width\":686,\"height\":435},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HighLight Capital China acquires stake in biotech company ITM\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HighLight Capital China acquires stake in biotech company ITM - FYB Financial Yearbook","description":"G\u00fctersloh\/Paderborn\/Bielefeld\/Detmold - HighLight Capital (HLC), a private equity fund from China specializing in the healthcare and biotech sectors, has acquired a stake in the biotech company ITM Isotope Technologies Munich SE (ITM). ITM is a leading radiopharmaceutical biotech company headquartered in Munich. BRANDI Rechtsanw\u00e4lte advised HighLight Capital on the investment in ITM.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/","og_locale":"en_US","og_type":"article","og_title":"HighLight Capital China acquires stake in biotech company ITM - FYB Financial Yearbook","og_description":"G\u00fctersloh\/Paderborn\/Bielefeld\/Detmold - HighLight Capital (HLC), a private equity fund from China specializing in the healthcare and biotech sectors, has acquired a stake in the biotech company ITM Isotope Technologies Munich SE (ITM). ITM is a leading radiopharmaceutical biotech company headquartered in Munich. BRANDI Rechtsanw\u00e4lte advised HighLight Capital on the investment in ITM.","og_url":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2024-11-27T11:56:40+00:00","og_image":[{"width":686,"height":435,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/dr-carsten-christophery-brandi-ra-brandi.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"HighLight Capital China acquires stake in biotech company ITM","datePublished":"2024-11-27T11:56:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/"},"wordCount":291,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/dr-carsten-christophery-brandi-ra-brandi.jpg","articleSection":["General","Featured","Private equity","News","Lawyers\/Tax-advisors\/Auditors","Lawyers, tax consultants, auditors","Investors","Consultant"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/","url":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/","name":"HighLight Capital China acquires stake in biotech company ITM - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/dr-carsten-christophery-brandi-ra-brandi.jpg","datePublished":"2024-11-27T11:56:40+00:00","description":"G\u00fctersloh\/Paderborn\/Bielefeld\/Detmold - HighLight Capital (HLC), a private equity fund from China specializing in the healthcare and biotech sectors, has acquired a stake in the biotech company ITM Isotope Technologies Munich SE (ITM). ITM is a leading radiopharmaceutical biotech company headquartered in Munich. BRANDI Rechtsanw\u00e4lte advised HighLight Capital on the investment in ITM.","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/dr-carsten-christophery-brandi-ra-brandi.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/dr-carsten-christophery-brandi-ra-brandi.jpg","width":686,"height":435},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/highlight-capital-china-acquires-stake-in-biotech-company-itm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"HighLight Capital China acquires stake in biotech company ITM"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/52963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=52963"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/52963\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/52961"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=52963"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=52963"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=52963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}